Fractional flow reserve-guided revascularization: practical implications of a diagnostic gray zone and measurement variability on clinical decisions.

[1]  A. Sollevi.  Cardiovascular effects of adenosine in man; possible clinical implications , 1986, Progress in Neurobiology.

[2]  P. Ganz,et al.  Reflex increase in blood pressure during the intracoronary administration of adenosine in man. , 1989, The Journal of clinical investigation.

[3]  A Bol,et al.  Coronary flow reserve calculated from pressure measurements in humans. Validation with positron emission tomography. , 1994, Circulation.

[4]  P. H. van der Voort,et al.  Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. , 1996, The New England journal of medicine.

[5]  W. Wijns,et al.  Simultaneous coronary pressure and flow velocity measurements in humans. Feasibility, reproducibility, and hemodynamic dependence of coronary flow velocity reserve, hyperemic flow versus pressure slope index, and fractional flow reserve. , 1996, Circulation.

[6]  M Siebes,et al.  Role of Variability in Microvascular Resistance on Fractional Flow Reserve and Coronary Blood Flow Velocity Reserve in Intermediate Coronary Lesions , 2001, Circulation.

[7]  William Wijns,et al.  Fractional Flow Reserve to Determine the Appropriateness of Angioplasty in Moderate Coronary Stenosis: A Randomized Trial , 2001, Circulation.

[8]  A. Fraser,et al.  Adenosine provokes diastolic dysfunction in microvascular angina , 2002, Postgraduate medical journal.

[9]  Maria Siebes,et al.  Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology. , 2006, Circulation.

[10]  William Wijns,et al.  Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. , 2007, Journal of the American College of Cardiology.

[11]  U. Siebert,et al.  Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. , 2009, The New England journal of medicine.

[12]  Volkmar Falk,et al.  Guidelines on Myocardial Revascularization the Task Force on Myocardial Revascularization of the European Society of Cardiology (esc) and the European Association for Cardio-thoracic Surgery (eacts) Developed with the Special Contribution of the European Association for Percutaneous Cardiovascular I , 2022 .

[13]  Kevin Kennedy,et al.  Appropriateness of percutaneous coronary intervention. , 2011, JAMA.

[14]  Nikola Jagic,et al.  Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. , 2012, The New England journal of medicine.

[15]  J. Spertus,et al.  ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, Am , 2012, Journal of the American College of Cardiology.

[16]  J. M. Cubero,et al.  A COMPARATIVE STUDY BETWEEN INTRAVENOUS AND INTRACORONARY ADMINISTRATION OF HIGH DOSES ADENOSINE FOR FRACTIONAL FLOW RESERVE MEASUREMENTS, IN THE “FAME” ERA , 2012 .

[17]  A. Hughes,et al.  Classification performance of instantaneous wave-free ratio (iFR) and fractional flow reserve in a clinical population of intermediate coronary stenoses: results of the ADVISE registry. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.